Progressive autologous graft-versus-host disease induced by cyclosporin A

J. C. Barredo, U. Yusuf, A. Hahn, M. R. Abboud, J. Laver

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


The development of graft-versus-host disease (GVHD) in patients undergoing allogeneic bone marrow transplantation for leukemias and lymphomas has been associated with a lower incidence of relapse. This phenomenen is thought to be secondary to the anti-tumor effect of adoptively transferred cells. Cyclosporin A (CsA) therapy is known to cause autologous and syngeneic GVHD in experimental models and humans, and has been used in patients undergoing autologous bone marrow transplantation. It has been the consensus to date that CsA-induced autologous GVHD is generally mild, confined to the skin, self-limiting and non-life-threatening. We report a case of severe and progressive GVHD induced by CsA in a child following autologous bone marrow transplantation for acute lymphoblastic leukemia in second remission.

Original languageEnglish (US)
Pages (from-to)659-662
Number of pages4
JournalBone Marrow Transplantation
Issue number3
StatePublished - Sep 1 1996
Externally publishedYes


  • Bone marrow transplantation
  • Cyclosporin A
  • Graft-versus-host disease

ASJC Scopus subject areas

  • Hematology
  • Transplantation


Dive into the research topics of 'Progressive autologous graft-versus-host disease induced by cyclosporin A'. Together they form a unique fingerprint.

Cite this